Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 31

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01212952Phase 1/2Completed
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Refractory Multiple Myeloma
PrincipalinvestigatorStart date: 2011-09-01
NCT01049945Phase 1/2Completed
Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Refractory Multiple Myeloma
PrincipalinvestigatorStart date: 2010-02-01
NCT00432458Phase 3Completed
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Principalinvestigator

Research Network

Collaboration Network

13 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shaji K. Kumar, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Refractory Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score24%

George Somlo, MD

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Mohamad A. Hussein, MD

The Cleveland Clinic

Related
8 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

William I. Bensinger, MD

Fred Hutchinson Cancer Center

Related
12 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Charles L. Loprinzi, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score15%

Jeffrey S. Weber, MD, PhD

University of Southern California

Related
9 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Leonard B. Saltz, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01212952Phase 1/2PrincipalInvestigator

Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma
Completed
NCT01049945Phase 1/2PrincipalInvestigator

Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Refractory Multiple Myeloma
Completed
NCT00432458Phase 3PrincipalInvestigator

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Completed

All 3 trials loaded